Louise Marston

Dr. Louise Marston

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in The British Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
JHJoseph F. Hayes
Joseph F. Hayes
LMLouise Marston
Louise Marston
KWKate Walters
Kate Walters
MKMichael B. King
Michael B. King
DODavid P. J. Osborn
David P. J. Osborn
Background: Bipolar disorder and schizophrenia are associated with increased mortality relative to the general population. There is an international emphasis on decreasing this excess mortality.Aims: To determine whether the mortality gap between individuals with bipolar disorder and schizophrenia and the general population has decreased.Method: A nationally representative cohort study using primary care electronic health records from 2000 to 2014, comparing all patients diagnosed with bipolar disorder or schizophrenia and the general population. The primary outcome was all-cause mortality.Results: Individuals with bipolar disorder and schizophrenia had elevated mortality (adjusted hazard ratio (HR) = 1.79, 95% CI 1.67–1.88 and 2.08, 95% CI 1.98–2.19 respectively). Adjusted HRs for bipolar disorder increased by 0.14/year (95% CI 0.10–0.19) from 2006 to 2014. The adjusted HRs for schizophrenia increased gradually from 2004 to 2010 (0.11/year, 95% CI 0.04–0.17) and rapidly after 2010 (0.34/year, 95% CI 0.18–0.49).Conclusions: The mortality gap between individuals with bipolar disorder and schizophrenia, and the general population is widening.

29 August 2002 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
AJAlice H. Johnson
Alice H. Johnson
JPJanet L. Peacock
Janet L. Peacock
AGAnne Greenough
Anne Greenough
NMNeil Marlow
Neil Marlow
ELElizabeth S. Limb
Elizabeth S. Limb
SCSandra A. Calvert
Sandra A. Calvert
There remains uncertainty concerning the safety and efficacy of high-frequency oscillatory ventilation as compared with those of conventional ventilation for the respiratory support of very preterm infants. We conducted a multicenter trial to determine whether early intervention with high-frequency oscillatory ventilation reduced mortality and the incidence of chronic lung disease among newborns with a gestational age of 28 weeks or less.

16 September 2015 in BMJ
Verified
Journal Article
Closed access
PDF file
PSPhilip Sedgwick
Philip Sedgwick
LMLouise Marston
Louise Marston

18 January 2012 in Pediatric Research
Verified
Journal Article
Closed access
JPJanet L. Peacock
Janet L. Peacock
LMLouise Marston
Louise Marston
NMNeil Marlow
Neil Marlow
SCSandra A. Calvert
Sandra A. Calvert
AGAnne Greenough
Anne Greenough

17 October 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NONeil E O'Connell
Neil E O'Connell
JCJohn Cossar
John Cossar
LMLouise Marston
Louise Marston
BWBenedict M Wand
Benedict M Wand
DBDavid Bunce
David Bunce
LSLorraine H De Souza
Lorraine H De Souza
Many double-blind clinical trials of transcranial direct current stimulation (tDCS) use stimulus intensities of 2 mA despite the fact that blinding has not been formally validated under these conditions. The aim of this study was to test the assumption that sham 2 mA tDCS achieves effective blinding. A randomised double blind crossover trial. 100 tDCS-naïve healthy volunteers were incorrectly advised that they there were taking part in a trial of tDCS on word memory. Participants attended for two separate sessions. In each session, they completed a word memory task, then received active or sham tDCS (order randomised) at 2 mA stimulation intensity for 20 minutes and then repeated the word memory task. They then judged whether they believed they had received active stimulation and rated their confidence in that judgement. The blinded assessor noted when red marks were observed at the electrode sites post-stimulation. tDCS at 2 mA was not effectively blinded. That is, participants correctly judged the stimulation condition greater than would be expected to by chance at both the first session (kappa level of agreement (κ) 0.28, 95% confidence interval (CI) 0.09 to 0.47 p = 0.005) and the second session (κ = 0.77, 95%CI 0.64 to 0.90), p = <0.001) indicating inadequate participant blinding. Redness at the reference electrode site was noticeable following active stimulation more than sham stimulation (session one, κ = 0.512, 95%CI 0.363 to 0.66, p<0.001; session two, κ = 0.677, 95%CI 0.534 to 0.82) indicating inadequate assessor blinding. Our results suggest that blinding in studies using tDCS at intensities of 2 mA is inadequate. Positive results from such studies should be interpreted with caution.

11 November 2013 in BMJ
Verified
Journal Article
Closed access
PDF file
NFNick Freemantle
Nick Freemantle
LMLouise Marston
Louise Marston
KWKate Walters
Kate Walters
JWJohn Wood
John Wood
MRMatthew R Reynolds
Matthew R Reynolds
IPIrene Petersen
Irene Petersen
Propensity score based methods are used increasingly to evaluate the effectiveness of treatments when evidence from randomised trials is not available. However, users need to be aware of their strengths and limitations